MedTrace Logo

Cardiovascular Events Based On Statin Initiation In The Elderly

NCT01304641 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31603

Last updated 2021-02-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare rates and risk of primary cardiovascular events among elderly patients newly initiating therapy with atorvastatin or simvastatin. The specific objectives for this project are to: 1) examine the demographic and clinical characteristics of the elderly patients in whom atorvastatin or simvastatin was newly initiated; and 2) compare cardiovascular event rates in elderly patients in whom atorvastatin or simvastatin was newly initiated.

Conditions

Interventions

OTHER

Atorvastatin Initiators

Retrospective database analysis no intervention performed.

OTHER

Simvastatin Initiators

Retrospective database analysis no intervention performed.

Sponsors & Collaborators

  • Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

    lead INDUSTRY

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2011-02-28
Completion
2011-02-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01304641 on ClinicalTrials.gov